Skip to content
Unrated Drug recall · FDA · Published May 15, 2025

Amerisource Health Services recalls Indomethacin capsules due to manufacturing deviations

Amerisource Health Services is recalling Indomethacin Extended-Release Capsules (75mg) due to cGMP deviations. This recall affects prescription-only products with specific lot numbers and expiration dates.

🇺🇸 FDA recall #D-0454-2025DrugAmerisource Health Services ›
Take action

Contact the company

Recalling firmAmerisource Health Services LLC2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

What happened, in plain English

Amerisource Health Services is recalling prescription Indomethacin Extended-Release Capsules (75mg) because of manufacturing deviations. This means the product may not be safe for use as intended. Read more at govinfonow.com/recall/32075-amerisource-health-services-recalls-indomethacin-capsules-due-to-manufacturing-deviations.

Source Summary by GovInfoNow · govinfonow.com/recall/32075-amerisource-health-services-recalls-indomethacin-capsules-due-to-manufacturing-deviations · Updated August 17, 2026 · FDA enforcement record: FDA #D-0454-2025

Cite this page

“Amerisource Health Services recalls Indomethacin capsules due to manufacturing deviations.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32075-amerisource-health-services-recalls-indomethacin-capsules-due-to-manufacturing-deviations. Based on FDA recall #D-0454-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0454-2025%22&limit=1).

Why it’s dangerous

The recall is due to cGMP (current Good Manufacturing Practice) deviations, which means the product was made under conditions that do not meet safety and quality standards. This could potentially affect the drug's effectiveness or safety, but the exact risk is not specified in the recall notice.

Who’s affected

Prescription patients who have received this specific lot number of Indomethacin Extended-Release Capsules. Those with medical conditions requiring this medication are at higher risk.

How to tell if you have this one

Check for the lot number 1021950 on the carton. The product expires November 30, 2026. This recall applies to prescription-only Indomethacin Extended-Release Capsules with the specific NDC numbers.

  • Brand
    Amerisource Health Services
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number on the carton is 1021950 and the expiration date is November 30, 2026.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 27 days after the firm started it.

1. Firm started the recall: May 15, 202512. FDA classified it Class II: Jun 2, 202523. Published in FDA’s Enforcement Report: Jun 11, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Amerisource Health Services recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0454-2025 (May 15, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0454-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA